MRNA - Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026
Story updates
02:21:11 PM UTC
SquawkNews
Phase 3 data for intismeran autogene in the adjuvant treatment of patients with resected stage IIB-IV melanoma selected for presentation at a Presidential SymposiumModerna to host an investor event via webcast on Saturday, October 24, at 7:00 PM CEST / 1:00 PM EDTCAMBRIDGE, MA / / S…